Ophthalmic Viscosurgical Devices Market 2018 Global Analysis By Key Players - Carl Zeiss Meditec, Bausch &Lomb, Rayner, CIMA Technology, Precision Lens, Hyaltech

The ophthalmic viscosurgical devices (OVD) market is poised to generate appreciable returns in the ensuing years, on account of the rising geriatric population that is more susceptible to ocular and ophthalmic conditions. According to a 2014 survey, the global geriatric population elevated from 9.2 percent in 1990 to 11.7 percent in 2013 and is anticipated to cross 21 percent by 2050, providing a solid base for the industry to flourish.

Market Study Report adds global Ophthalmic Viscosurgical Devices market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years. The coming years will witness economies increasing their dependence on IoT devices and services.

Dispersive OVDs market offers advantages of using the viscoelastic soft-shell technique for routine cases, especially for complex procedures, which could result in more than 12% CAGR by 2024. Cohesive ophthalmic viscosurgical devices market will seize close to 40% share by 2024, due to their tendency to stick together and move as a mass, which plays an important role in OVD retention in the anterior chamber during phacoemulsification. Some of the available viscous cohesive OVDs are Provisc, Healon, Amvisc and Amvisc Plus.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467898/

Rising incidences of diabetes, with most diabetic people suffering from conditions like blindness and diabetic retinopathy, would pave way for astounding growth of the ophthalmic viscosurgical devices market. In a recent turn of events, Amring Pharmaceuticals Inc., a generic pharma company, has reportedly announced the launch of its latest product, called Biolon OVD. Through this development, Amring is bringing Biolon OVD to cataract surgeons in the US, which is already been used by surgeons across the globe. Similarly, other market majors will also be seen undertaking initiatives that enhance their market share and global reach, thereby producing promising opportunities for ophthalmic viscosurgical devices market players.

Europe ophthalmic viscosurgical devices market, especially across Germany, UK and France will experience notable growth; the region accounted for more than 30% of the 2015 global revenue. Demographic shift is set to lead to an increase in the overall sales of Intraocular Lens (IOLs). Age-related macular degeneration (AMD), glaucoma and diabetic retinopathy are the most common cause of blindness in Europe.

Companies operating in ophthalmic viscosurgical devices market include Alcon, Abbott Medical Optics, Carl Zeiss Meditec, Bausch &Lomb, Rayner, CIMA Technology, Precision Lens, Hyaltech, Maxigen Biotech, etc. Medical device manufacturers that can introduce novel innovative equipment will have huge benefits in the developing regions.

Increasing diabetic retinopathy cases and cataract surgical rates coupled with availability of new drugs and devices will boost the Latin America ophthalmic viscosurgical devices market size. The region is filled with immense potential for growth; with Vision 2020 advocacy, governments are considering cataract surgery as a priority, providing treatment free of cost. Argentina could be a profitable region with significantly high number of surgeries being conducted.

2015 U.S. ophthalmic viscosurgical devices market was valued over USD 125 million and is forecast to rise during the coming years with growing geriatric population base, increasing number of minimally invasive surgeries and favorable government policies.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467898/

Japan ophthalmic viscosurgical devices market share has witnessed highest gains in 2015 due to prevalence of diabetic retinopathy, high myopia, optic nerve and retinochoroidal degeneration. Cataract prevalence is one of the major cause of blindness in China which will drive the regional ophthalmic viscosurgical devices market over the forecast period. Pure sodium hyaluronate product is currently widely used in China.

For More Detail on This Report: https://www.marketstudyreport.com/reports/ophthalmic-viscosurgical-devices-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
MarketStudyReport.com
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.